SH2B3 and systemic lupus erythematosus: CD21−/lo B cells, a population also reported to be elevated in SLE patients (Wehr et al., 2004), showed a trend of increase in two SLE patients carrying rare SH2B3 variants and other SLE patients (Fig. 3 J).